Latest Blogs

Aug 11, 2022
Dr. Tara Rajendran celebrates the legacy and mentorship of Dr. Karen Jean Marcus upon her retirement after 33-year career at the Dana-Farber Cancer Institute.
Jul 27, 2022
Dr. Anna M Laucis discusses the landscape and future opportunities for narrative medicine, along with her own explorations in original artwork and poetry.
Jul 21, 2022
It feels great to celebrate 17 consecutive years of organizing the Best of ASCO Lebanon meeting, including a well-received event featuring expert faculty in 2022.
Jul 19, 2022
Cancer changes the relationship between what we think is certain and the fallibility of our assumptions; it can also be a source of discovery about ourselves and our relationships.
Subscribe to this column

Linda R. Duska, MD, MPH

Linda R. Duska, MD, MPH, is the editor in chief of ASCO Connection. She is the associate dean of clinical research and a professor of obstetrics and gynecology at the University of Virginia School of Medicine. Since joining ASCO in 1999, she has served on the Scientific Program, Cancer Education, and Public Issues Committees, and as a faculty member at ASCO Annual Meetings, among numerous volunteer roles. 

Disclosure.

Sep 13, 2022
There has never been a more pertinent moment for all of us to consider how we can engage with colleagues in other countries to solve the problems of cancer. 
Jul 20, 2022
The weeks following the ASCO Annual Meeting always feel like a bit of a reset, as we emerge energized from connecting with friends and colleagues.
May 12, 2022
Since ASCO22 will be offered as a hybrid meeting, with both an in-person and a virtual experience, we get the best of both worlds.
Mar 15, 2022
Let's consider the progress that has been made as well as the work that still needs to be done to reach gender equity in our profession.
Jan 20, 2022
What do we mean when we say that equity, diversity, and inclusion is not one thing, it’s everything?
Jan 06, 2022
Dr. Leslie M. Randall, Dr. Mark Stoler, and I explore the decline in cervical cancer incidence which has not corresponded to a decline in deaths from high-risk invasive disease. 

Pages